Results 261 to 270 of about 16,988,510 (382)

Development of a core outcome set for intraventricular haemorrhage (IVH) in preterm infants: a study protocol. [PDF]

BMJ Open
Dou H, Li Y, Li YX, Yang Y, Zhang Y, Wu J, Liu D, Mao Y, Shi J, Tang J, Xiong T.   +10 more
europepmc   +1 more source

Competing Outcomes [PDF]

Journal of the National Comprehensive Cancer Network, 2005
openaire   +2 more sources

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Journal of the American Medical Association (JAMA), 1998
Jun Zhang, K. Yu
semanticscholar   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

2009 National curriculum tests review outcomes (provisional) [PDF]

, 2009

core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

The reporting outcomes in medical education (ROME) model: proposition of a new framework. [PDF]

BMC Med Educ
Kerth JL, Lehmann R, Wells JW, Leopardi E, Morgan RL, Neubacher M, Yepes-Nuñez JJ, Bosse HM.   +7 more
europepmc   +1 more source

The response to ranibizumab therapy after three injections predicts 12-month outcomes in DME in the absence of rescue laser therapy.

, 2016
Joanna Dilley, Simon Taylor
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

The impact of federations on student outcomes [PDF]

, 2009
Armstrong, Paul, Chapman, Christopher, Collins, Alison, Muijs, Daniel, Sammons, Pam   +4 more
core